The global rapid STI testing market is estimated at approximately USD 1.74 billion in 2026 and is projected to grow to approximately USD 3.75 billion by 2035, reflecting an estimated CAGR of 8.9%. The market growth is driven by increased STI screening, asymptomatic infections, decentralized and near-patient testing, and advances in molecular diagnostics.Â
